Caterina Gianni Giuseppe Bronte Angelo Delmonte Marco Angelo Burgio Kalliopi Andrikou Manlio Monti Cecilia Menna Giovanni Luca Frassineti Lucio Crinò
10.3389/fphar.2021.672233
Front Pharmacol
2021 Aug 12;12:672233.
liver toxicity non-small cell lung cancer osimertinib pembrolizumab stevens johnson syndrome
CC BY
https://pubmed.ncbi.nlm.nih.gov/34456717/
Case Reports
PMC8397522
34456717
Case Report: Stevens-Johnson Syndrome and Hepatotoxicity Induced by Osimertinib Sequential to Pembrolizumab in a Patient With EGFR-Mutated Lung Adenocarcinoma
2021